How to Inject Retatrutide: Best Sites, Needles and Steps

Retatrutide goes under the skin once a week, into the fatty layer of your stomach, the front of your thigh or the back of your upper arm. No published study has compared those sites for retatrutide itself, and for tirzepatide and semaglutide, its closest approved relatives, the FDA labels say all three give similar blood levels. So how to inject retatrutide well comes down mostly to needle length and rotation, and both are well studied in insulin users.

As of September 2026, retatrutide is still in Phase 3 trials and no approved version exists yet. Lilly plans to file for FDA approval in the first quarter of 2027, according to its second-quarter 2026 results, which leaves no retatrutide Instructions for Use to quote. This page leans instead on the FDA-approved instructions for Zepbound (tirzepatide) and Wegovy (semaglutide) as class evidence, plus injection research from insulin users, and says which is which.

Where to inject reta

The three areas below are the ones the tirzepatide and semaglutide labels list. Lilly's Zepbound instructions and Novo Nordisk's Wegovy instructions agree on the stomach and thighs and differ slightly on the arm.

Where weekly shots under the skin go

The three areas in the instructions for approved weekly injections in the same class

Stomach area, keeping about 2 inches (5 cm) away from the belly button

Front of the thighs, between the hip and the middle of the thigh

Back of the upper arms. This spot is easier if someone else gives the shot.

Between them, the two sets of instructions say to skip skin that is tender, bruised, red, scaly or hard, and to skip scars or damaged skin. Zepbound's also rule out pits, thickened skin and lumps, and Wegovy's rule out stretch marks. MedlinePlus insulin guidance says to keep shots 1 inch (2.5 cm) away from scars.

Some guides add the upper outer buttock. Insulin users inject there, but neither the Zepbound nor the Wegovy label lists it, and it's a hard spot to see on yourself.

The published retatrutide trials all gave the drug as a once-weekly injection under the skin: the Phase 1b trial in The Lancet (72 people), the Phase 2 obesity trial in NEJM (338 adults) and the Phase 3 TRANSCEND-T2D-1 trial (537 adults). The published summaries don't say which body sites were used.

Is the stomach or the thigh the best place to inject retatrutide?

No published study answers that for retatrutide. The class evidence points one way, though. The Zepbound label states that "similar exposure was achieved" whether tirzepatide went into the abdomen, thigh or upper arm, and the Wegovy label says the same of semaglutide, using the same words. That's tirzepatide and semaglutide data, not retatrutide.

Retatrutide's own site data is thin. Lilly ran a Phase 1 study (NCT06003465) that compared blood levels of retatrutide given with two different injection devices in 57 healthy adults. It finished in February 2024 and has posted no results. Some websites quote exact percentage differences in peak levels between stomach and thigh shots of retatrutide; we couldn't find a published source for any of them.

What does differ between sites is the depth of fat under the skin. In an ultrasound study of 388 US adults with diabetes (Gibney and colleagues, 2010), the average fat layer was:

Women had 5.1 mm more fat on average than men, and 10 points of body mass index (BMI) shifted it by about 4 mm. Of the three label sites, the stomach gives a longer needle the most room.

Our read: pick the area you can reach and see, and rotate inside it. On the evidence above, needle length and rotation will matter more for you than stomach versus thigh.

Needles for reta, and why length matters more than gauge

If your retatrutide comes as a vial, you'll draw each dose with an insulin syringe. These are U-100 syringes: MedlinePlus explains that standard insulin has 100 units in 1 mL, so each unit is 0.01 mL whatever you put in it. A 0.3 mL syringe holds 30 units, a 0.5 mL syringe 50, and a 1 mL syringe 100. How many units your dose is depends on how much water went into the vial, which our retatrutide calculator works out for you.

Needle length is printed on the box, usually in inches: 15/64 inch is 6 mm, 5/16 inch is 8 mm and 1/2 inch is 12.7 mm. It matters because skin is thin everywhere: 1.9 to 2.4 mm on average in the Gibney study, and it barely changed with weight, sex or race. The fat layer below varies far more. The same study found that needles 8 mm or longer, pushed straight in, may often reach muscle in the arms and legs of men and of people with a BMI under 25, while 4 to 5 mm needles at 90 degrees reached the fat layer with minimal risk of hitting muscle in virtually all adults.

The FITTER recommendations, written by 183 diabetes experts from 54 countries and published in Mayo Clinic Proceedings in 2016, call the shortest needles (4 mm for pens, 6 mm for syringes) safe, effective and less painful, and say to avoid injecting into muscle. That's insulin research. Nobody has tested what happens to retatrutide injected into muscle, and the Wegovy instructions tell users of that drug not to inject into a muscle or vein.

Gauge is thickness, and a higher number means a thinner needle.

Our read: with an 8 mm or 12.7 mm syringe needle, pinch up a fold or angle the needle, especially in the thigh or arm or if you're lean. A 6 mm needle leaves more room to spare.

How to inject retatrutide with a syringe

These steps follow the FDA-approved Zepbound single-dose vial instructions, adapted to a retatrutide vial. Mixing a powder vial is a separate job with its own page: how to reconstitute retatrutide.

1. Gather a new insulin syringe, an alcohol swab, gauze or a cotton ball, and a sharps container.
2. Take the vial from the fridge and check it. Zepbound's instructions say not to use medicine that is frozen, cloudy or has particles. If your retatrutide looks cloudy, stop and read what cloudy retatrutide means.
3. Wash your hands with soap and water, then wipe the vial's rubber stopper with an alcohol swab.
4. Pull the plunger back to draw in air equal to your dose, push the needle through the stopper and push that air into the vial.
5. Turn the vial and syringe upside down, keep the needle tip in the liquid, and draw slightly past your dose line. Tap out any bubbles, then push back to the exact line.
6. Pull the needle out of the vial and choose your site. If you clean the skin with alcohol, let it dry fully first, as the Wegovy instructions say.
7. Pinch a fold if your needle length and build call for it, then insert the needle in one smooth motion.
8. Push the plunger all the way down. Leave the needle in for at least 5 seconds, as both the Zepbound instructions and MedlinePlus say, so the whole dose goes in.
9. Pull the needle out. If there's a drop of blood, press with gauze and don't rub.
10. Put the syringe straight into the sharps container without recapping it. Recapping is how needle-stick injuries happen, Lilly's instructions note.

One thing Lilly's vial instructions can't cover is the vial itself. None of the retatrutide for sale online is Lilly's product, so the amount in the vial and its sterility rest on the seller's own batch testing. That can go badly wrong. In an alert published on September 14, 2026, Australia's TGA said its lab found no retatrutide in a vial sold as retatrutide, only undeclared semaglutide at about 8 times the level in approved semaglutide products.

If you'd rather not handle syringes, Lilly has studied a retatrutide injection device, and our retatrutide pen page tracks what's known.

How far apart to space your shots

Rotate every week, even within the same area. The Zepbound instructions give the reason: changing the site each dose lowers your risk of lipodystrophy (pits or thickened skin) and localized cutaneous amyloidosis (lumps). The FITTER insulin recommendations call lumpy, thickened patches (lipohypertrophy) a frequent complication of insulin injections that distorts absorption, and say to keep shots out of them.

Neither label gives a set distance between shots. One simple pattern: use the stomach in 4 quarters around the belly button (upper left, upper right, lower left, lower right), keeping 2 inches from the navel, and move to the thighs when you want a break. MedlinePlus suggests keeping a chart of the places you've used.

Retatrutide's half-life was about 6 days in the Phase 1b trial in The Lancet, and its authors said that suits once-weekly dosing. A phone note with each date and spot covers both the schedule and the rotation.

Can you mix reta with other peptides in one syringe?

No study has tested retatrutide mixed in a syringe with anything else, including peptides people stack with it, such as GHK-Cu. The closest official guidance is class evidence: the Zepbound instructions say not to mix tirzepatide with any other medicine and not to inject it at the site used for other medicines. Two separate syringes in two separate spots avoid the question entirely.

Other mistakes that cause trouble:

• Reusing a syringe. Lilly's instructions call for a new syringe and needle every time, to prevent infections and blocked needles, and never sharing them.
• Loading a syringe hours or days ahead. No one has published stability data for a retatrutide dose left sitting in a syringe in the fridge, and Lilly's vial instructions have you draw the dose and inject it in one sitting.
• Injecting before the alcohol on your skin has dried. The Wegovy instructions say to let the skin dry first.
• Using the same patch week after week because it hurts least. The lumps that build up there are what the rotation rule is meant to prevent.
• Tossing loose needles in the trash. The FDA says to put sharps in a sharps container right away and dispose of the container by your local rules. If you don't have one, Lilly's instructions describe a heavy-duty plastic household container with a tight, puncture-resistant lid, labeled as hazardous waste, and say not to recycle it.

Signs a shot needs a doctor's eye

Site problems look uncommon so far. In the retatrutide Phase 2 obesity trial, the results posted on ClinicalTrials.gov list every side effect that reached 5% in any dose group, and no injection-site event made that list. Our page on retatrutide injection site reactions covers redness, itching, bruises and small lumps in detail.

If a needle breaks off in the skin, a question that turns up on r/Retatrutide, don't dig for it. Get it seen by a doctor or an urgent care clinic.

Burning or oversensitive skin far from where you injected is a separate side effect (dysesthesia). People on r/Retatrutide describe it as skin pain or hypersensitivity across the body, and no trial has tested whether changing injection sites helps. Tell your doctor about it, along with any shot that hurts more each week instead of less.